Trial
NCT06376253
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Ovarian Cancer
Intervention
[68Ga]Ga-EVS459
Why stopped
Study termination based on sponsor decision due to lack of tolerability observed with \[177Lu\]Lu-EVS459
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23